These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15185496)

  • 1. End-stage renal disease and dialysis in hereditary amyloidosis TTR V30M: presentation, survival and prognostic factors.
    Lobato L; Beirão I; Silva M; Fonseca I; Queirós J; Rocha G; Sarmento AM; Sousa A; Sequeiros J
    Amyloid; 2004 Mar; 11(1):27-37. PubMed ID: 15185496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ineffectiveness of dialysis in transthyretin (TTR) clearance in familial amyloid polyneuropathy type I, in spite of lower stability of the TTR Met30 variant.
    Beirão I; Lobato L; Riedstra S; Costa PM; Pimentel S; Guimarães S
    Clin Nephrol; 1999 Jan; 51(1):45-9. PubMed ID: 9988146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of end-stage renal disease after liver transplantation in transthyretin amyloidosis (ATTR V30M).
    Rocha A; Lobato L; Silva H; Beirão I; Santos J; Pessegueiro H; Almeida R; Cabrita A
    Transplant Proc; 2011; 43(1):189-93. PubMed ID: 21335185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transthyretin amyloidosis and the kidney.
    Lobato L; Rocha A
    Clin J Am Soc Nephrol; 2012 Aug; 7(8):1337-46. PubMed ID: 22537653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portuguese-type amyloidosis (transthyretin amyloidosis, ATTR V30M).
    Lobato L
    J Nephrol; 2003; 16(3):438-42. PubMed ID: 12832749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Familial amyloid polyneuropathies: therapeutic issues].
    Adams D; Cauquil C; Théaudin M
    Bull Acad Natl Med; 2012 Oct; 196(7):1333-45; discussion 1345-7. PubMed ID: 23815018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in Survival and Renal Recovery in Patients with Multiple Myeloma or Light-Chain Amyloidosis on Chronic Dialysis.
    Decourt A; Gondouin B; Delaroziere JC; Brunet P; Sallée M; Burtey S; Dussol B; Ivanov V; Costello R; Couchoud C; Jourde-Chiche N
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):431-41. PubMed ID: 26728585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial ATTR amyloidosis: microalbuminuria as a predictor of symptomatic disease and clinical nephropathy.
    Lobato L; Beirão I; Silva M; Bravo F; Silvestre F; Guimarães S; Sousa A; Noël LH; Sequeiros J
    Nephrol Dial Transplant; 2003 Mar; 18(3):532-8. PubMed ID: 12584275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced myocardial 123-iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy.
    Coutinho MC; Cortez-Dias N; Cantinho G; Conceição I; Oliveira A; Bordalo e Sá A; Gonçalves S; Almeida AG; de Carvalho M; Diogo AN
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):627-36. PubMed ID: 23833285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
    Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of familial amyloid polyneuropathy].
    Adams D; Samuel D; Slama M
    Presse Med; 2012 Sep; 41(9 Pt 1):793-806. PubMed ID: 22341949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. End-stage renal disease in systemic amyloidosis: clinical course and outcome on dialysis.
    Martinez-Vea A; García C; Carreras M; Revert L; Oliver JA
    Am J Nephrol; 1990; 10(4):283-9. PubMed ID: 2240055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF; McCarthy M; Howse ML; Williams PS
    Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
    Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M;
    Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is lower urinary tract dysfunction an early marker of Portuguese type familial amyloidotic polyneuropathy in women? Preliminary results.
    Gomes MJ; Martins Silva A; Salinas Casado J; Castro Diaz D; Figueiredo A; Singla A; Rosier P; Silva C; Fuente Carvalho L; Rizk D
    Arch Esp Urol; 2014 Jul; 67(6):557-64. PubMed ID: 25048588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. End-stage renal failure due to transthyretin amyloidosis after liver transplantation: outcomes in 19 registry cases.
    Rocha A; Beirão I; Pessegueiro H; Almeida R; Lobato L
    Amyloid; 2017 Mar; 24(sup1):85-86. PubMed ID: 28434351
    [No Abstract]   [Full Text] [Related]  

  • 19. CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings.
    Maia LF; Magalhães R; Freitas J; Taipa R; Pires MM; Osório H; Dias D; Pessegueiro H; Correia M; Coelho T
    J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):159-67. PubMed ID: 25091367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes mellitus and dialysis.
    Stein G; Fünfstück R; Schiel R
    Minerva Urol Nefrol; 2004 Sep; 56(3):289-303. PubMed ID: 15467507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.